Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00700102 · BASELINE

Baseline characteristics

A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. · Source last updated 2015-07-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      411
    2. group Id
      BG001
      value
      409
    3. group Id
      BG002
      value
      820
    units
    Participants
groups
  1. description
    Chemotherapy alone until disease progression, unacceptable toxicity, or patient refusal Chemotherapy: As prescribed
    id
    BG000
    title
    Chemotherapy
  2. description
    Chemotherapy and Bevacizumab until disease progression, unacceptable toxicity, or patient refusal Chemotherapy: As prescribed Bevacizumab: Bevacizumab, 5 mg/kg intravenously (IV) on days 1 and 14 of each 4 week cycle, or 7.5 mg/kg IV on days 1 and 22 of each 6 week cycle.
    id
    BG001
    title
    Chemotherapy + Bevacizumab
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.55
          value
          61.9
        2. group Id
          BG001
          spread
          9.78
          value
          62.1
        3. group Id
          BG002
          spread
          9.66
          value
          62.0
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          152
        2. group Id
          BG001
          value
          142
        3. group Id
          BG002
          value
          294
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          259
        2. group Id
          BG001
          value
          267
        3. group Id
          BG002
          value
          526
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      411
    2. group Id
      BG001
      value
      409
    3. group Id
      BG002
      value
      820
    units
    Participants
groups
  1. description
    Chemotherapy alone until disease progression, unacceptable toxicity, or patient refusal Chemotherapy: As prescribed
    id
    BG000
    title
    Chemotherapy
  2. description
    Chemotherapy and Bevacizumab until disease progression, unacceptable toxicity, or patient refusal Chemotherapy: As prescribed Bevacizumab: Bevacizumab, 5 mg/kg intravenously (IV) on days 1 and 14 of each 4 week cycle, or 7.5 mg/kg IV on days 1 and 22 of each 6 week cycle.
    id
    BG001
    title
    Chemotherapy + Bevacizumab
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.55
          value
          61.9
        2. group Id
          BG001
          spread
          9.78
          value
          62.1
        3. group Id
          BG002
          spread
          9.66
          value
          62.0
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          152
        2. group Id
          BG001
          value
          142
        3. group Id
          BG002
          value
          294
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          259
        2. group Id
          BG001
          value
          267
        3. group Id
          BG002
          value
          526
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice